Cargando…

Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma

SIMPLE SUMMARY: Although craniopharyngiomas are pathologically defined as benign tumors, their lesions could involve the hypothalamic–pituitary axis and adjacent to several important anatomical structures. Treatment strategies, including surgery and radiation, have a higher risk of damaging these im...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Lidong, Zhu, Hongtao, Wang, Jing, Wu, Sisi, Zhang, Suojun, Wang, Junwen, Shu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856947/
https://www.ncbi.nlm.nih.gov/pubmed/36672290
http://dx.doi.org/10.3390/cancers15020340
_version_ 1784873753964969984
author Cheng, Lidong
Zhu, Hongtao
Wang, Jing
Wu, Sisi
Zhang, Suojun
Wang, Junwen
Shu, Kai
author_facet Cheng, Lidong
Zhu, Hongtao
Wang, Jing
Wu, Sisi
Zhang, Suojun
Wang, Junwen
Shu, Kai
author_sort Cheng, Lidong
collection PubMed
description SIMPLE SUMMARY: Although craniopharyngiomas are pathologically defined as benign tumors, their lesions could involve the hypothalamic–pituitary axis and adjacent to several important anatomical structures. Treatment strategies, including surgery and radiation, have a higher risk of damaging these important structures, which leads to excess recurrence and disability rates. Endocrine deficiencies caused by hypothalamic–pituitary axis damage are the most common symptoms and postoperative complications of craniopharyngioma patients, which severely affect perioperative and long-term treatment effects. However, limited studies have focused on the endocrine deficiencies of craniopharyngioma patients. In this study, the influencing factors and replacement therapies for pre- and postoperative pituitary hormone deficiency were retrospectively analyzed in 126 craniopharyngioma patients, which provides evidence for surgical strategy selection and long-term management during craniopharyngioma treatments. ABSTRACT: Background: Pituitary hormone deficiency (PHD) is one of the most common symptoms and postoperative complications of craniopharyngiomas (CPs). However, the risk factors for PHD in CPs are little known. The purpose of this study was to analyze the risk factors of pre- and postoperative PHD and to investigate replacement therapy for CP patients. Methods: A retrospective study of 126 patients diagnosed with CP was performed. Univariate analysis was performed using Pearson’s chi-squared test or Fisher’s exact test, and a multiple logistic binary regression model was used to identify the influencing factors of pre- and postoperative PHD in craniopharyngioma. Results: Children and patients with hypothalamic involvement were more likely to have preoperative PHD. Patients with suprasellar lesions had a high risk of postoperative PHD, and preoperative PHD was a risk factor for postoperative PHD. Conclusion: Children have a high incidence of preoperative PHD. Preoperative PHD can serve as an independent risk factor for postoperative PHD. Preoperative panhypopituitarism can serve as an indication of pituitary stalk sacrifice during surgery. The management of replacement therapy for long-term postoperative endocrine hormone deficiency in patients with craniopharyngioma should be enhanced.
format Online
Article
Text
id pubmed-9856947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98569472023-01-21 Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma Cheng, Lidong Zhu, Hongtao Wang, Jing Wu, Sisi Zhang, Suojun Wang, Junwen Shu, Kai Cancers (Basel) Article SIMPLE SUMMARY: Although craniopharyngiomas are pathologically defined as benign tumors, their lesions could involve the hypothalamic–pituitary axis and adjacent to several important anatomical structures. Treatment strategies, including surgery and radiation, have a higher risk of damaging these important structures, which leads to excess recurrence and disability rates. Endocrine deficiencies caused by hypothalamic–pituitary axis damage are the most common symptoms and postoperative complications of craniopharyngioma patients, which severely affect perioperative and long-term treatment effects. However, limited studies have focused on the endocrine deficiencies of craniopharyngioma patients. In this study, the influencing factors and replacement therapies for pre- and postoperative pituitary hormone deficiency were retrospectively analyzed in 126 craniopharyngioma patients, which provides evidence for surgical strategy selection and long-term management during craniopharyngioma treatments. ABSTRACT: Background: Pituitary hormone deficiency (PHD) is one of the most common symptoms and postoperative complications of craniopharyngiomas (CPs). However, the risk factors for PHD in CPs are little known. The purpose of this study was to analyze the risk factors of pre- and postoperative PHD and to investigate replacement therapy for CP patients. Methods: A retrospective study of 126 patients diagnosed with CP was performed. Univariate analysis was performed using Pearson’s chi-squared test or Fisher’s exact test, and a multiple logistic binary regression model was used to identify the influencing factors of pre- and postoperative PHD in craniopharyngioma. Results: Children and patients with hypothalamic involvement were more likely to have preoperative PHD. Patients with suprasellar lesions had a high risk of postoperative PHD, and preoperative PHD was a risk factor for postoperative PHD. Conclusion: Children have a high incidence of preoperative PHD. Preoperative PHD can serve as an independent risk factor for postoperative PHD. Preoperative panhypopituitarism can serve as an indication of pituitary stalk sacrifice during surgery. The management of replacement therapy for long-term postoperative endocrine hormone deficiency in patients with craniopharyngioma should be enhanced. MDPI 2023-01-04 /pmc/articles/PMC9856947/ /pubmed/36672290 http://dx.doi.org/10.3390/cancers15020340 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cheng, Lidong
Zhu, Hongtao
Wang, Jing
Wu, Sisi
Zhang, Suojun
Wang, Junwen
Shu, Kai
Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
title Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
title_full Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
title_fullStr Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
title_full_unstemmed Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
title_short Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
title_sort risk factor and replacement therapy analysis of pre- and postoperative endocrine deficiencies for craniopharyngioma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856947/
https://www.ncbi.nlm.nih.gov/pubmed/36672290
http://dx.doi.org/10.3390/cancers15020340
work_keys_str_mv AT chenglidong riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma
AT zhuhongtao riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma
AT wangjing riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma
AT wusisi riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma
AT zhangsuojun riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma
AT wangjunwen riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma
AT shukai riskfactorandreplacementtherapyanalysisofpreandpostoperativeendocrinedeficienciesforcraniopharyngioma